147 related articles for article (PubMed ID: 20682141)
1. Intrauterine device use among women with ovarian cancer: a systematic review.
Zapata LB; Whiteman MK; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):38-40. PubMed ID: 20682141
[TBL] [Abstract][Full Text] [Related]
2. Intrauterine device use among women with uterine fibroids: a systematic review.
Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
[TBL] [Abstract][Full Text] [Related]
3. Complications and continuation of intrauterine device use among commercially insured teenagers.
Berenson AB; Tan A; Hirth JM; Wilkinson GS
Obstet Gynecol; 2013 May; 121(5):951-958. PubMed ID: 23635730
[TBL] [Abstract][Full Text] [Related]
4. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
6. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
7. Use of contraceptive methods among women with endometrial hyperplasia: a systematic review.
Whiteman MK; Zapata LB; Tepper NK; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):56-63. PubMed ID: 20682143
[TBL] [Abstract][Full Text] [Related]
8. Use of intrauterine devices in nulliparous women.
Lohr PA; Lyus R; Prager S
Contraception; 2017 Jun; 95(6):529-537. PubMed ID: 27591814
[TBL] [Abstract][Full Text] [Related]
9. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
[TBL] [Abstract][Full Text] [Related]
10. [Reasons for removal of intrauterine devices among women in general practice].
Kolding L; Majeed HG
Ugeskr Laeger; 2013 Mar; 175(13):884-6. PubMed ID: 23582897
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.
Achilles SL; Chen BA; Lee JK; Gariepy AM; Creinin MD
Contraception; 2015 Dec; 92(6):572-4. PubMed ID: 26297203
[TBL] [Abstract][Full Text] [Related]
12. Selection and performance of the levonorgestrel-releasing intrauterine system.
Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
[TBL] [Abstract][Full Text] [Related]
13. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
Bilgehan F; Dilbaz B; Karadag B; Deveci CD
J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer.
Dinger J; Bardenheuer K; Minh TD
Contraception; 2011 Mar; 83(3):211-7. PubMed ID: 21310281
[TBL] [Abstract][Full Text] [Related]
15. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study.
Barnett C; Moehner S; Do Minh T; Heinemann K
Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):424-428. PubMed ID: 29322856
[TBL] [Abstract][Full Text] [Related]
16. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant.
Bahamondes L; Hidalgo M; Petta CA; Diaz J; Espejo-Arce X; Monteiro-Dantas C
J Reprod Med; 2003 Aug; 48(8):637-40. PubMed ID: 12971147
[TBL] [Abstract][Full Text] [Related]
17. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel intrauterine device (IUD) exacerbation of PMS symptoms.
Appiani FJ; Carroll BT
Ann Clin Psychiatry; 2014 May; 26(2):146-7. PubMed ID: 24812652
[No Abstract] [Full Text] [Related]
19. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
20. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]